- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03187041
Sensation and Skin Pressures Under Blood-Draw Tourniquets
Skin Surface Pressures Under Blood-Draw Tourniquets
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The objective of this study is to investigate the reproducibility and consequently the safety of common elastic tourniquet methods for blood draws. Specifically, the study will investigate whether the surface pressures produced by blood draw tourniquets when applied by experienced phlebotomists are significant enough to penetrate to deeper tissue near bone where major arteries and nerves lie. By relating factors including tourniquet width and patient arm circumference to our surface pressure measurements and comparing our results to previous literature, the investigators hope to determine the safety of current blood draw tourniquet procedures.
In addition, the investigators will track changes in skin surface pressures over time to determine if prolonged exposure to these tourniquet pressures has the potential to permanently affect nerve function and muscle in tissues near bone.
Hand sensation will be investigated during a prolonged tourniquet application trial of the study to test the effects of the generated pressures on median, ulnar, and radial nerve viability over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92103
- UC San Diego Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years or older
Exclusion Criteria:
- no history of abnormal heart conditions
- no history of coagulation disorders
- will not be on prescription medications that affect cardiovascular system (ex: medications that affect blood pressure or cardiac contractility etc.)**
does not have diabetes
- Types of medications that affect the cardiovascular system and are part of the exclusion criteria include but are not limited to: anticoagulants, antiaginals, antiarrhythmic agents, anti-hypertensive/hypotensive agents, cardenolides, cardiac stimulants, hypolipidemic agents, inotropic agents, vasoconstrictors, as well as vasodilators.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Skin surface pressures under tourniquets and sensation
Phase 1: Each phlebotomist will apply the tourniquet 10 separate times to the right arm of each subject. The tourniquet will remain on the arm for approximately ten seconds, to be able to allot enough time to collect an accurate pressure measurement. All 10 tourniquet skin pressure measurements will take place on the same day for a subject. Phase 2: 20 subjects will be subjected to a prolonged blood-draw tourniquet application for a duration of 1 hour. The purpose of phase 2 is to determine whether there is an effect on sensation from prolonged blood tourniquet use. |
Phase 1: Skin surface pressures will be recorded by an investigator during each of the 10 applications of the tourniquet. All 10 tourniquet skin pressure measurements will take place in the Blood Draw clinic at the UCSD Medical Center in Hillcrest on the same day for a subject. Phase 2: The same 20 subjects will be subjected to a prolonged blood-draw tourniquet application for a duration of 70 minutes. The purpose of phase 2 is to determine whether there is an effect on sensation from prolonged blood tourniquet use. External skin pressures will not exceed 60mmHg. During this prolonged tourniquet application the investigators will monitor changes in hand sensation at 10-minute intervals using Semmes-Weinstein monofilaments on three peripheral nerves of the hand (median, radian, and ulnar). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Skin Surface Pressure Under Blood-Draw Tourniquet with Phlebotomists (Phase 1)
Time Frame: Phase 1: 10-15 seconds (10 times within a 5 -10 minute period)
|
The pressure under blood draw tourniquets will be taken in Phases 1 and 2. During phase 1, the tourniquet will remain on the subject for a brief period of time (10-15 seconds) 10 times, allowing for enough time to acquire pressure measurements using the PicoPress device.
The difference between Phase 1 and Phase 2 is that phase 1 will be performed with a phlebotomist, while phase 2 will be performed with one of the investigators for an extended period of time.
|
Phase 1: 10-15 seconds (10 times within a 5 -10 minute period)
|
Skin Surface Pressure Under Blood-Draw Tourniquet and Change in sensation during a 1 hour period (Phase 2)
Time Frame: Phase 2: 70 minutes (sensation will be measured every 10 minutes)
|
Phase 2: The PicoPress will constantly monitor pressure under the arm tourniquet for one hour.
The investigators will also simultaneously monitor the changes from baseline in sensation using Semmes-Weinstein Monofilaments on the radial, ulnar, and median nerves in participants.
|
Phase 2: 70 minutes (sensation will be measured every 10 minutes)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alan R Hargens, PhD, UCSD
Publications and helpful links
General Publications
- Crenshaw AG, Hargens AR, Gershuni DH, Rydevik B. Wide tourniquet cuffs more effective at lower inflation pressures. Acta Orthop Scand. 1988 Aug;59(4):447-51. doi: 10.3109/17453678809149401.
- Partsch H, Mosti G. Comparison of three portable instruments to measure compression pressure. Int Angiol. 2010 Oct;29(5):426-30.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 161885
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Pressures Under Blood Draw-tourniquets
-
Johns Hopkins UniversityLouisiana State University Health Sciences Center in New OrleansRecruitingScleroderma | Mildly Elevated Pulmonary PressuresUnited States
-
Brigham and Women's HospitalCompletedFibromyalgia | Chronic Fatigue Syndrome | Orthostatic Hypotension | Postural Orthostatic Tachycardia Syndrome | Dysautonomia | Myalgic Encephalomyelitis | Exercise Intolerance | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Low Ventricular Filling Pressures (Preload Failure)United States
Clinical Trials on Sensation and Skin Surface Pressures Under Blood-Draw Tourniquets
-
Memorial Sloan Kettering Cancer CenterYale University; University of New MexicoCompleted
-
National Institute of Allergy and Infectious Diseases...RecruitingLyme Disease | Tick-borne Diseases | Tick ResistanceUnited States
-
Children's Hospital Medical Center, CincinnatiBioMarin PharmaceuticalCompleted
-
National Institute of Allergy and Infectious Diseases...Consortium of Food Allergy ResearchTerminated
-
National Institute of Allergy and Infectious Diseases...Completed
-
St. Jude Children's Research HospitalUniversity of Wisconsin, MadisonCompletedRetinoblastomaUnited States
-
National Jewish HealthSuspendedFood Allergy in ChildrenUnited States
-
Kansas State UniversityRecruitingBreast Cancer | Head and Neck Cancer | Chemotherapy Effect | Gastrointestinal Cancer | 5-Fluorouracil ToxicityUnited States
-
Innovaderm Research Inc.RecruitingPlaque Psoriasis | Atopic Dermatitis | Hidradenitis Suppurativa | Palmoplantar Pustulosis | Acne | Chronic Hand EczemaCanada
-
National Jewish HealthUnknownAllergy | Pregnancy Related | Asthma in Children | Food Allergy | Atopic Dermatitis EczemaUnited States